Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behrouz Mansouri Taleghani
Erwin Strasser

Showing results (41-50 of 109) with videos related to

Pageof 11
Sort By:
Cancers|February 25, 2022
Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AMLEkaterina Gurevich, Michael Hayoz, Yolanda Aebi, et al.
Leukemia Research|June 26, 2012
The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potentialIsabelle von Grünigen, Joëlle Raschle, Ilka Rüsges-Wolter, et al.
Hematological Oncology|August 16, 2018
Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patientsSarah Farag, Barbara Jeker, Ulrike Bacher, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|April 17, 2023
Principles of Therapeutic Apheresis in Neurological DiseaseErwin Strasser
Hematological Oncology|August 3, 2022
Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patientsMelanie Maechler, Ulrike Bacher, Michael Daskalakis, et al.
British Journal of Haematology|September 13, 2014
Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemiaDana Wetzel, Beatrice U Mueller, Behrouz Mansouri Taleghani, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 24, 2014
A Simple Guideline Reduces the Need for Red Blood Cell Transfusions in Swiss Hospitals: A Prospective, Multicentre, Before-and-After Study in Elective Hip and Knee ReplacementStefano Fontana, Cristina de la Cuadra, Urs Müller, et al.
Transfusion|September 12, 2018
Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemiaLaura C Alva, Ulrike Bacher, Katja Seipel, et al.
Transfusion Medicine Reviews|February 1, 2021
Immunoadsorption for the Treatment of Acquired Hemophilia: New Observational Data, Systematic Review, and Meta-AnalysisMichael Esteves Pereira, Christoph Bocksrucker, Johanna Anna Kremer Hovinga, et al.
Leukemia & Lymphoma|August 22, 2015
Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicityBeatrice U Mueller, Sandra Keller, Katja Seipel, et al.
Pageof 11

Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Cancers|February 25, 2022
Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AMLEkaterina Gurevich, Michael Hayoz, Yolanda Aebi, et al.
Leukemia Research|June 26, 2012
The relapse risk of AML patients undergoing autologous transplantation correlates with the stem cell mobilizing potentialIsabelle von Grünigen, Joëlle Raschle, Ilka Rüsges-Wolter, et al.
Hematological Oncology|August 16, 2018
Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patientsSarah Farag, Barbara Jeker, Ulrike Bacher, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|April 17, 2023
Principles of Therapeutic Apheresis in Neurological DiseaseErwin Strasser
Hematological Oncology|August 3, 2022
Long-term safety of the stem cell releasing compound plerixafor for peripheral stem cell collection in myeloma patientsMelanie Maechler, Ulrike Bacher, Michael Daskalakis, et al.
British Journal of Haematology|September 13, 2014
Delayed Haematological recovery after autologous stem cell transplantation is associated with favourable outcome in acute myeloid leukaemiaDana Wetzel, Beatrice U Mueller, Behrouz Mansouri Taleghani, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|July 24, 2014
A Simple Guideline Reduces the Need for Red Blood Cell Transfusions in Swiss Hospitals: A Prospective, Multicentre, Before-and-After Study in Elective Hip and Knee ReplacementStefano Fontana, Cristina de la Cuadra, Urs Müller, et al.
Transfusion|September 12, 2018
Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemiaLaura C Alva, Ulrike Bacher, Katja Seipel, et al.
Transfusion Medicine Reviews|February 1, 2021
Immunoadsorption for the Treatment of Acquired Hemophilia: New Observational Data, Systematic Review, and Meta-AnalysisMichael Esteves Pereira, Christoph Bocksrucker, Johanna Anna Kremer Hovinga, et al.
Leukemia & Lymphoma|August 22, 2015
Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicityBeatrice U Mueller, Sandra Keller, Katja Seipel, et al.
Pageof 11